Publications
- Lapatinib in second line treatment of metastatic HER2+ breast cancer2012 | First Faculty of Medicine
- Aromatase inhibitors and their place in the adjuvant treatment of breast cancer2008 | First Faculty of Medicine
- Changes in the presence of circulating tumor cells in the peripheral blood of breast cancer patients during the course of treatmentPublication without faculty affiliation
- Prevention, diagnosis and treatment of cancer-associated thromboembolism2023 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové, Faculty of Medicine in Pilsen
- Karcinom prsu - výzvy pro rok 20232023 | First Faculty of Medicine
- Standing ovations jsou zasloužené2023 | First Faculty of Medicine
- Therapeutic options in patients with early breast cancer2023 | First Faculty of Medicine
- A přesto je palbociklib užitečný lék2023 | First Faculty of Medicine
- Neoadjuvant treatment of HER2-positive breast cance2023 | First Faculty of Medicine
- Trastuzumab deruxtecan as standard of care for second-line treatment of metastatic HER2-positive breast cancer2023 | First Faculty of Medicine
Loading network view...